Article
Plasma levels of unactivated thrombin activatable fibrinolysis inhibitor (TAFI) are down-regulated in young adult women: analysis of a normal Japanese population.
Microbiology and immunology - 1 Jan 2007
Akatsu Hiroyasu, Ishiguro Masae, Ogawa Norihiro, Kanesaka Takeshi, Okada Noriko, Yamamoto Takayuki, Campbell William, Okada Hidechika
Abstract excerpt
Thrombin-activatable fibrinolysis inhibitor (TAFI) is an anaphylatoxin-inactivating enzyme generated by proteolytic cleavage of its zymogen, and is the same enzyme as that first designated by our group as procarboxypeptidase R (proCPR). TAFI in plasma is presumed to influence vascular disease in its role as a fibrinolysis inhibitor. The activity of TAFI is strongly influenced by genetic polymorphism, especially...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
